Papers

2

Total Citations

17

H-Index

2

About

Michael Chow is a head and neck surgeon whose research focuses on advancing minimally invasive surgical techniques for the treatment of aerodigestive tract malignancies, particularly laryngeal and oropharyngeal cancers. His major contributions center on evaluating and comparing the efficacy of transoral robotic surgery (TORS) against traditional open approaches and transoral laser microsurgery (TLM). His most-cited work, a 2023 study on TORS for early-stage supraglottic larynx carcinoma (14 citations), provides critical evidence that robotic surgery can achieve comparable oncologic outcomes with potentially reduced morbidity, helping to shift surgical paradigms toward less invasive options. Chow also explores the challenging clinical entity of head and neck cancer of unknown primary, offering a surgical perspective that guides diagnostic and therapeutic decision-making. His research directly impacts surgical practice by clarifying the role of emerging technologies in head and neck oncology. With a growing citation record and a focus on patient-centered outcomes, Chow is establishing himself as a thoughtful contributor to the evolution of transoral surgery, bridging the gap between technological innovation and clinical application for the benefit of patients with complex head and neck cancers.

Research Focus

Key Achievements

2
H-Index
2
Papers
17
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Role of transoral robotic surgery in surgical treatment of early‐stage supraglottic larynx carcinoma
14 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: NYU Langone Health, University of California, San Francisco

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago